Prof. Terence Kee, Singapore
Impact of mRNA COVID-19 vaccination on clinical outcomes of COVID-19 infection in kidney transplant recipients at the Singapore General Hospital

Miss Constance Chui Wan Lee, Singapore
Safe living kidney donor transplantation during the COVID-19 Pandemic - Experience from the Singapore General Hospital

Dr. Asimina Fylaktou, Greece
Ηumoral and cellular SARS-CoV-2 immunity in renal transplant recipients following BNT162b2 mRNA vaccination

Dr. Amy Chang, United States
Differential Immunogenicity of mRNA-1273 versus BNT162b2 as a Third Vaccine Dose for Solid Organ Transplant Recipients Seronegative after Two BNT162b2 Doses

Dr. Rachel VT Hogen, United States
COVID-19 Positive Donor Organs in Liver Transplantation

Dr. Hailey J Hardgrave, United States
Undetectable Recipient COVID-19 Plasma PCR Following COVID-19 Positive Donor Kidney Transplant: Proof of Concept Analysis

Mr. Lawrence Suplee, United States
Timely lower respiratory SARS-CoV-2 testing of all potential organ donors leads to successful transplantation of organs from SARS-CoV-2+ donors

Monica Nakamura, Brazil
The high incidence of Long-COVID-19 in kidney transplant recipients: a longitudinal cohort study

Dr. Alfredo Chew-Wong, Mexico
Seroconversion after vaccination with BNT162b2 Pfizer/BioNTech, ChAdOx1 nCoV-19/AZD1222 and coronavac against sars-cov-2 among hemodialysis and kidney transplant patients